Bai Cheng Medicine: Jia Fei plans to reduce his shareholding by 0.0112% within three months.

Announcement from Baicheng Pharmaceuticals: Director and senior management member Jia Fei holds 48,908 shares, accounting for 0.0451% of the total shares. He plans to reduce his holdings by no more than 12,200 shares, or 0.0112% within 3 months after the announcement date; Director Song Bofan holds 9,337 shares, accounting for 0.0086%, and plans to reduce his holdings by no more than 2,300 shares, or 0.0021%; Director Yan Hongbing holds 38,145 shares, accounting for 0.0352%, and plans to reduce his holdings by no more than 9,500 shares, or 0.0088%; Senior management member Chen An holds 45,000 shares, accounting for 0.0415%, and plans to reduce his holdings by no more than 11,200 shares, or 0.0103%.